Search research articles
Contact Us
Filters
Showing results (31-40 of 128) with videos related to
Page
of 13
Sort By:
Chemico-Biological Interactions
|
May 7, 2003
New findings in the study on the intercalation of bisdaunorubicin and its monomeric analogues with naked and nucleus DNA
Hayet Tayeb-Bel Haj, Milena Salerno, Waldemar Priebe, et al.
Frontiers in Immunology
|
June 18, 2025
STAT3 inhibition in combination with CD47 blockade inhibits osteosarcoma lung metastasis
Pradeep Shrestha, Rejeena Shrestha, You Zhou, et al.
Pharmaceuticals (Basel, Switzerland)
|
April 29, 2020
Drug Conjugates for Targeting Eph Receptors in Glioblastoma
Puja Sharma, Callie Roberts, Denise Herpai, et al.
The Journal of Surgical Research
|
October 27, 2004
WP744 is a novel anthracycline with enhanced activity against neuroblastoma
Thomas H Inge, Nathaniel L Harris, Jianqiang Wu, et al.
European Journal of Medicinal Chemistry
|
August 23, 2003
Structure and biological activity of cationic [PtLCl(DMSO)]NO(3).DMSO complex containing a chelated diaminosugar: methyl-3,4-diamino-2,3,4,6-tetradeoxy-alpha-L-lyxopyranoside
Leon Fuks, Krystyna Samochocka, Romana Anulewicz-Ostrowska, et al.
Anticancer Research
|
September 15, 2005
Relationship between topoisomerase II-DNA cleavable complexes, apoptosis and cytotoxic activity of anthracyclines in human cervix carcinoma cells
Beata M Gruber, Elzbieta L Anuszewska, Irena Bubko, et al.
Molecular Cancer Therapeutics
|
November 16, 2004
Enhanced topoisomerase II targeting by annamycin and related 4-demethoxy anthracycline analogues
Alex V Trevino, Barbara A Woynarowska, Terence S Herman, et al.
Archivum Immunologiae Et Therapiae Experimentalis
|
June 9, 2007
Effect of structural modification at the 4, 3', and 2' positions of doxorubicin on topoisomerase II poisoning, apoptosis, and cytotoxicity in human melanoma cells
Beata M Gruber, Elzbieta L Anuszewska, Irena Bubko, et al.
Molecular Pharmaceutics
|
May 13, 2025
Harnessing Electrophiles In Vivo: A Pilot Study in Swine Using a Hydrophobic Radiopaque Formulation of 2-Propylpentanoyl Chloride
Erik Cressman, Danielle Stolley, Natalie Fowlkes, et al.
Acta Poloniae Pharmaceutica
|
May 23, 2007
Topoisomerase II alpha expression and cytotoxicity of anthracyclines in human neoplastic cells
Beata M Gruber, Elzbieta L Anuszewska, Iza Roman, et al.
Page
of 13
Search research articles
Search
Showing results (31-40 of 128) with videos related to
Sort By:
Page
of 13
Chemico-Biological Interactions
|
May 7, 2003
New findings in the study on the intercalation of bisdaunorubicin and its monomeric analogues with naked and nucleus DNA
Hayet Tayeb-Bel Haj, Milena Salerno, Waldemar Priebe, et al.
Frontiers in Immunology
|
June 18, 2025
STAT3 inhibition in combination with CD47 blockade inhibits osteosarcoma lung metastasis
Pradeep Shrestha, Rejeena Shrestha, You Zhou, et al.
Pharmaceuticals (Basel, Switzerland)
|
April 29, 2020
Drug Conjugates for Targeting Eph Receptors in Glioblastoma
Puja Sharma, Callie Roberts, Denise Herpai, et al.
The Journal of Surgical Research
|
October 27, 2004
WP744 is a novel anthracycline with enhanced activity against neuroblastoma
Thomas H Inge, Nathaniel L Harris, Jianqiang Wu, et al.
European Journal of Medicinal Chemistry
|
August 23, 2003
Structure and biological activity of cationic [PtLCl(DMSO)]NO(3).DMSO complex containing a chelated diaminosugar: methyl-3,4-diamino-2,3,4,6-tetradeoxy-alpha-L-lyxopyranoside
Leon Fuks, Krystyna Samochocka, Romana Anulewicz-Ostrowska, et al.
Anticancer Research
|
September 15, 2005
Relationship between topoisomerase II-DNA cleavable complexes, apoptosis and cytotoxic activity of anthracyclines in human cervix carcinoma cells
Beata M Gruber, Elzbieta L Anuszewska, Irena Bubko, et al.
Molecular Cancer Therapeutics
|
November 16, 2004
Enhanced topoisomerase II targeting by annamycin and related 4-demethoxy anthracycline analogues
Alex V Trevino, Barbara A Woynarowska, Terence S Herman, et al.
Archivum Immunologiae Et Therapiae Experimentalis
|
June 9, 2007
Effect of structural modification at the 4, 3', and 2' positions of doxorubicin on topoisomerase II poisoning, apoptosis, and cytotoxicity in human melanoma cells
Beata M Gruber, Elzbieta L Anuszewska, Irena Bubko, et al.
Molecular Pharmaceutics
|
May 13, 2025
Harnessing Electrophiles In Vivo: A Pilot Study in Swine Using a Hydrophobic Radiopaque Formulation of 2-Propylpentanoyl Chloride
Erik Cressman, Danielle Stolley, Natalie Fowlkes, et al.
Acta Poloniae Pharmaceutica
|
May 23, 2007
Topoisomerase II alpha expression and cytotoxicity of anthracyclines in human neoplastic cells
Beata M Gruber, Elzbieta L Anuszewska, Iza Roman, et al.
Page
of 13